Cell growth inhibition, G 2 /M cell cycle arrest, and apoptosis induced by chloroquine in human breast cancer cell line Bcap-37

Cellular Physiology and Biochemistry

Volumn 22, Issue 5-6, 2008, Pages 431-440

  Jiang, Pei Du ^a   Zhao, Ying Lan ^a   Shi, Wei ^a   Deng, Xiao Qiang ^a   Xie, Gang ^a   Mao, Yong Qiu ^a   Li, Zheng Guang ^a   Zheng, Yu Zhu ^a   Yang, Sheng Yong ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Bcap 37 breast cancer cells; Cell cycle; Chloroquine; G 2 M arrest

Indexed keywords

ALPHA TUBULIN; CASPASE 3; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25C; CHLOROQUINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLO LIKE KINASE 1; PROTEIN KINASE B; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SPINDLE CELL; WESTERN BLOTTING;

EID: 57649184991     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000185488     Document Type: Article

References (54)

1. Sams WM: Chloroquine: mechanism of action. Mayo Clin Proc 1967;42:300-309.
2. Bedoya V: Effect of chloroquine on malignant lymphoreticular and pigmented cells in vitro. Cancer Res 1970;30:1262-1275.
3. Zeilhofer HU, Mollenhauer J, Brune K: Selective growth inhibition of ductal pancreatic adenocarcinoma cells by the lysosomotropic agent chloroquine. Cance Lett 1989;44:61-66.
4. Inoue S, Hasegawa K, Ito S, Wakamatsu K, Fujita K: Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin. Pigm Cell Res 1993;6:354-358.
5. Potvin F, Petitclerc E, Marceau F, Poubelle PE: Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells. J Immunology 1997;158:1872-1879.
6. Zaidi AU, McDonough JS, Klocke BJ, Latham CB, Korsmeyer SJ, Flavell RA, Schmidt RE, Roth KA: Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol 2001;60:937-945.
7. Parris GE: Hypothesis links emergence of chloroquine-resistant malaria and other intracellular pathogens and suggests a new strategy for treatment of diseases caused by intracellular parasites. Med Hypotheses 2004;62:354-357.
8. Chen TH, Chang PC, Chang MC, Lin YF, Lee HM: Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells. Pharmacol Res 2005;51:329-336.
9. Zhao H, Cai Y, Santi S, Lafrenie R, Lee H: Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis. Radiat Res 2005;164:250-257.
10. Fan CD, Wang WW, Zhao BX, Zhang SL, Miao JY: Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorgan Med Chem 2006;14:3218-3222.
11. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin 2007;57:43-66.
12. Shoemaker JP, Bradley RL, Hoffman RV: Mammary cancer: increased survival and decreased rate of tumor growth with chloroquine. Intern Res Commun System Med Sci-Library Compendium 1977;5:555.
13. Shoemaker JP: Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine. Cancer Res 1978;38:2700-2702.
14. Schwarts GK, Shah MA: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005;23:9408-9421.
15. Sebolt-Leopold JS, Herrera R: Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 2004;4:937-947.
16. Nicholson KM, Anderson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002;14:381-395.
17. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-277.
18. Wang XJ, Wei YQ, Yuan SL, Liu GJ, Lu YR, Zhang J, Wang WD: Potential anticancer activity of litchi pericarp extract against hepatocellular carcinoma in vitro and in vivo. Cancer Lett 2006;239:144-150.
19. Gumireddy K, Reddy MV, Cosenza SC, Nathan RB, Baker SJ, Papathi N, Jiang JD, Holland J, Reddy EP: ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell 2005;7:275-286.
20. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975;66:188-193.
21. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A: Induction of apoptosis by quercertin: involvement of heat shock protein. Cancer Res 1994;54:4952-4957.
22. Militao GC, Dantas IN, Pessoa C, Falcao MJ, Silveira ER, Lima MA, Curi R, Lima T, Moraes MO, Costa-Lotufo LV: Induction of apoptosis by pterocarpans from platymiscium floribundum in HL-60 human leukemia cells. Life Sci 2006;78:2409-2417.
23. Lippman ME, Allegra JC, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC, Warren R: The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med 1978;298:1223-1228.
24. Maehara Y, Emi Y, Sakaguchi Y, Kusumoto T, Kakeji Y, Kohnoe S, Sugimachi K: Estrogen-receptor-negative breast cancer tissue is chemosensitive in vitro compared with estrogen-receptor-positive tissue. Eur Surg Res 1990;22:50-55.
25. Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP: Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2006;295:1658-1667.
26. Sui M, Huang Y, Park BH, Davidson NE, Fan W: Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Cancer Res 2007;67:5337-5344.
27. Loehberg CR, Thompson T, Kastan MB, Maclean KH, Edwards DG, Kittrell FS, Medina D, Conneely OM, O.Malley BW: Ataxia telanqiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis. Cancer Res 2007;67:12026-12033.
28. Yang S, Zhou Q, Yang X: Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta 2007;1773:903-911.
29. McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL: c-Myc overexpression and endocrine resistance in breast cancer J Steroid Biochem Mol Biol 2006;102:147-155.
30. Rossi T, Coppi A, Bruni E, Ruberto A, Santachiara S, Baggio G: Effects of antimalarial drugs on MCF-7 and vero cell replication. Anticancer Res 2007;27:2555-2560.
31. Bai XH, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye KQ, Murad E, Dubiel W, Soff G, Arbiser JL: Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo J Biol Chem 2003;278:35501-35507.
32. Zhou Q, McCracken MA, Strobl JS: Control of mammary tumor cell growth in vitro by novel cell differentiation and apoptosis agents. Breast Cancer Res Treat 2002;75:107-117.
33. Holtrich U, Wolf G, Brauninger A, Karn T, Bohme B, Rubsamen-Waigmann H, Strebhardt K: Induction and downregulation of Plk, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci USA 1994;91:1736-1740.
34. Dai W: Polo-like kinases, an introduction. Oncogene 2005;24:214-216.
35. van Vugt MA, Medema RH: Getting in and out of mitosis with polo-like kinase-1. Oncogene 2005;24:2844-2859.
36. Reagan-Shaw S, Ahmad N: Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. FASEB J 2005;19:611-613.
37. Erikson E, Haystead TA, Qian YW, Maller JL. A feedback loop in the polo-like kinase activation pathway. J Biol Chem 2004;279:32219-32224.
38. 2 -M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 2006;5:3209-3221.
39. 2 /M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA 1999;96:11335-11340.
40. 2 /M transition induced by nocodazole. J Biol Chem 2000;275:31876-31882.
41. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G: Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003;22:3927-3936.
42. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309-1312.
43. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-1544.
44. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G: Molecular characterization of mitochondrial apoptosis-inducing factors. Nature 1999;397:441-446.
45. Hengartner MO: The biochemistry of apoptosis. Nature 2000;407:770-776.
46. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316.
47. Zhang MC, Liu HP, Demchik LL, Zhai YF, Yang DJ: Light sensitizes IFNgamma-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways. Cell Res 2004;142:117-124.
48. Hyman AA, Karsenti E: Morphogenetic properties of microtubules and mitotic spindle assembly. Cell 1996;84:401-410.
49. Nasmyth K: Segregating sister genomes: the molecular biology of chromosome separation. Science 2002;297:559-565.
50. Sasaki JI, Ramesh R, Chada S, Gomyo Y, Roth JA, Mukhopadhyay T: The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther 2002;1:1201-1209.
51. Bonness K, Aragon IV, Rutland B, Ofori-Acquah S, Dean NM, Honkanen RE: Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aα. Mol Cancer Ther 2006;5:2727-2736.
52. Reszka AA, Bulinski JC, Krebs EG, Fischer EH: Mitogen-activated protein kinase/extracellular signal-regulated kinase 2 regulates cytoskeletal organization and chemotaxis via catalytic and microtubule-specific interactions. Mol Biol Cell 1997;8:1219-1232.
53. Gotoh Y, Nishida E, Matsuda S, Shiina N, Kosako H, Shiokawa K, Akiyama T, Ohta K, Sakai H: In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase. Nature 1991;349:251-254.
54. Lovric J, Dammeier S, Kieser A, Mischak H, Kolch W: Activated Raf induces the hyperphosphorylation of the microtubule network. J Biol Chem 1998;273:22848-22855.